发明名称 |
Influenza hemagglutinin proteins and methods of use thereof |
摘要 |
In some embodiments the present invention provides influenza hemagglutinin (“HA”) polypeptides, proteins, and protein complexes that comprise a stalk domain that is engineered to facilitate maintenance of its native trimeric conformation, even if the head domain of the HA protein is removed or disrupted. In some embodiments, the present invention provides compositions comprising such polypeptides, proteins, and protein complexes, and methods of use of such proteins and compositions, for example as vaccine immunogens. |
申请公布号 |
US9393297(B2) |
申请公布日期 |
2016.07.19 |
申请号 |
US201414450236 |
申请日期 |
2014.08.02 |
申请人 |
AVATAR MEDICAL, LLC |
发明人 |
Marshall Christopher Patrick;Alff Peter Joseph;Bertuccioli Claudio;Yondola Mark Andrew |
分类号 |
A61K39/145;C12N7/00;A61K45/06;C07K14/005 |
主分类号 |
A61K39/145 |
代理机构 |
Grimes & Yvon LLP |
代理人 |
Grimes & Yvon LLP |
主权项 |
1. An influenza hemagglutinin (HA) polypeptide, protein or protein complex comprising an amino acid sequence having at least 65% sequence identity to amino acid residues 229 to 519 of SEQ ID NO: 1, wherein the amino acid sequence comprises a point mutation to tyrosine at one or more of amino acid positions 403, 406, 429, 432, 433, and 435, or an amino acid residue corresponding thereto. |
地址 |
New York NY US |